均衡营养和度:在一个体外研究中的蛋白质强化剂的个体化强化过程中,高度的风险
Laxman Basany1, Abid Ali1, Naga Priyanka G Gandrakota1
1Neonatology, Ankura Hospital for Women and Children, Hyderabad, IND.
用多组分强化剂 (MCFs) 对母乳进行个性化强化可以增加度. 仔细选择MCF和蛋白质强化剂 (PF) 对于保持早产婴儿安全的度水平至关重要.
科学领域:
- 新生儿营养新生儿营养
- 儿科胃肠病学 儿科胃肠病学
- 生物化学 生物化学
背景情况:
- 用蛋白质强化剂 (PFs) 和脂肪强化剂 (FFs) 个性化强化母乳对于早产婴儿至关重要.
- 强化增加母乳度,可能会影响婴儿的耐受性.
- 多成分强化剂 (MCF) 对母乳度的影响需要评估.
研究的目的:
- 评估各种MCF对挤出母乳 (EBM) 度的影响.
- 为了确定MCFs和PFs对EBM度的综合作用.
- 为了确定早产婴儿营养的安全强化限值.
主要方法:
- 用六种MCF,早成型配方 (PTF),PF和FF强化的EBM的度测量.
- 用MCF测量无菌水的度,以评估仅强化剂的影响.
- 逐步将PF添加到强化母乳 (FHM) 中,以确定安全限值 (<450mOsm/kg).
主要成果:
- MCF增加了EBM度,不同MCF之间存在差异 (MCF4: 428 mOsm/kg,MCF6: 327 mOsm/kg).
- 将PF添加到FHM中可能会超过安全的度值,这取决于MCF类型和PF数量.
- 脂肪强化剂 (FFs) 并没有显著改变EBM度.
结论:
- MCFs增加EBM的度,但通常在安全范围内.
- 将MCF与PF结合起来需要仔细选择和剂量调整,以保持度低于450mOsm/kg.
- 优化强化策略是满足早产婴儿营养需求的关键,同时确保安全.
更多相关视频
04:53A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
12:43Genetic and Biochemical Approaches for In Vivo and In Vitro Assessment of Protein Oligomerization: The Ryanodine Receptor Case Study
Published on: July 27, 2016
相关概念视频
One-Compartment Open Model for IV Bolus Administration: General Considerations
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
Electrolytes: van't Hoff Factor
The colligative properties of a solution depend only on the number, not on the identity, of solute species dissolved. The concentration terms in the equations for various colligative properties (freezing point depression, boiling point elevation, osmotic pressure) pertain to all solute species present in the solution. Nonelectrolytes dissolve physically without dissociation or any other accompanying process. Each molecule that dissolves yields one...
One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
Osmosis and Osmotic Pressure of Solutions
